Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

Novasep Sold for EUR 425 Million

Princeton, NJ (Nov. 30)-Rockwood Holdings, Inc. agreed to sell its Group Novasep subsidiary for EUR 425 million ($567 million) to a consortium of buyers consisting of Glide Buyout Partners BV, Banexi Capital, and Group Novasep management.

Princeton, NJ (Nov. 30)-Rockwood Holdings, Inc. (www.rockwoodspecialties.com) agreed to sell its Groupe Novasep (Pompey, France, www.novasep.com) subsidiary for EUR 425 million ($567 million) to a consortium of buyers consisting of Glide Buyout Partners BV, Banexi Capital, and Group Novasep management. Rockwood currently owns 78.6% of Novasep, and Novasep management holds the other 21.4%.

Groupe Novasep specializes in producing active pharmaceutical ingredients and intermediates, developing new purification processes, and large-scale chromatography. The company will continue to operate through two complementary divisions: Novasep Synthesis, the custom synthesis unit, and Novasep Process, the purification and chromatography unit. These two divisions have sales of roughly EUR 280 million ($374 million). 

Novasep operates mainly in Europe (France and Germany) with subsidiaries in the United States, China, Latin America and Japan. It has roughly 1300 employees at nine manufacturing sites.

Rockwood merged Groupe Novasep with the custom manufacturer Dynamic Synthesis in 2004. Earlier this year, Rockwood divested Rohner AG (Pratteln, Switzerland), a contract manufacturer of APIs and intermediates.

The transaction is expected to close in 60 days.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content